← Leaderboards
Robert Page Edwards
Roswell Park Cancer Institute Corp
$5,636,497
Attributed
$9,099,633
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,679,133 · 7
By mechanism
P50$7,772,491 · 2
U10$4,494,569 · 1
P01$1,740,617 · 1
K12$1,661,456 · 2
R13$10,000 · 1
Top collaborators
- Adam M Brufsky5 shared
- Dwight E Heron5 shared
- John Munn Kirkwood5 shared
- Ronald J Buckanovich3 shared
- Mark A Socinski2 shared
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Wei Zheng$71,826,577
- Christine B. Ambrosone$40,409,261
- John David Carpten$9,472,293
- Clement C Ip$9,662,404
- Kirsten B Moysich$9,727,320
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsMalignant NeoplasmsFutureFundingScienceResearch PersonnelBaseChemotherapySiteClinical TrialsMalignant Neoplasm Of OvaryRecurrenceMediatingResponseWomanImmuneCancer PatientScientistTumor MicroenvironmentCessation Of LifeTechnologyCareerCareer DevelopmentLead
Grant awards (21)
HCC Ovarian Cancer SPORE$2,250,657
P50 · FY2025 · CA
Project 1: EZH2 Inhibition to Prevent/Overcome Chemoresistance$344,428
P50 · FY2025 · CA · contact PI
University of Pittsburgh/Magee-Womens Research Institute Women's Reproductive Health Research Across the Lifespan (Pitt-MWRI WRHR)$339,191
K12 · FY2025 · HD · contact PI
HCC Ovarian Cancer SPORE$2,165,016
P50 · FY2024 · CA
Project 1: EZH2 Inhibition to Prevent/Overcome Chemoresistance$487,172
P50 · FY2024 · CA · contact PI
HCC Ovarian Cancer SPORE$2,163,827
P50 · FY2023 · CA
Project 2: Local immunotherapy corrects chemokine patterns in ovarian cancer$576,791
P01 · FY2023 · CA · contact PI
Project 1: EZH2 Inhibition to Prevent/Overcome Chemoresistance$361,391
P50 · FY2023 · CA · contact PI
Project 2: Local immunotherapy corrects chemokine patterns in ovarian cancer$585,174
P01 · FY2021 · CA · contact PI
Project 2: Local immunotherapy corrects chemokine patterns in ovarian cancer$578,652
P01 · FY2020 · CA · contact PI
Magee-Womens Basic and Translational Reproductive Health Training Program$199,664
K12 · FY2019 · HD · contact PI
NCI NCTN-Network Lead Academic Site at UPCI$898,424
U10 · FY2018 · CA
Magee-Womens Basic and Translational Reproductive Health Training Program$100,001
K12 · FY2018 · HD · contact PI
NCI NCTN-Network Lead Academic Site at UPCI$898,445
U10 · FY2017 · CA
Magee-Womens Basic and Translational Reproductive Health Training Program$340,200
K12 · FY2017 · HD · contact PI
NCI NCTN-Network Lead Academic Site at UPCI$853,523
U10 · FY2016 · CA
Magee-Womens Basic and Translational Reproductive Health Training Program$340,200
K12 · FY2016 · HD · contact PI
NCI NCTN-Network Lead Academic Site at UPCI$898,445
U10 · FY2015 · CA
Magee-Womens Basic and Translational Reproductive Health Training Program$342,200
K12 · FY2015 · HD · contact PI
NCI NCTN-Network Lead Academic Site at UPCI$945,732
U10 · FY2014 · CA
Ovarian Cancer: Prevention of the Disease and Its Recurrence$10,000
R13 · FY2012 · CA · contact PI